Brief: Medipharm Labs Enters Into $6.2 Mln Purchase Agreement For Sale Of Australian Facility

Medipharm Labs

11/07/2022 12:58

July 11 (Reuters) - Medipharm Labs Corp  LABS.TO :
    * MEDIPHARM LABS ENTERS INTO $6.2M PURCHASE AGREEMENT FOR
THE SALE
OF AUSTRALIAN FACILITY
    * MEDIPHARM LABS CORP - AGREEMENT IS SUBJECT TO ROUTINE
CONDITIONS
AND IS ANTICIPATED TO CLOSE WITHIN 90 DAYS
    * MEDIPHARM LABS CORP - ALL INTERNATIONAL CONTRACTS OUTSIDE
OF
AUSTRALIA AND NEW ZEALAND WILL REMAIN WITH CO AND BE SERVICED
FROM BARRIE GMP FACILITY
    * MEDIPHARM - DEAL INCLUDES ASSETS OF MPLA, SPECIALIZED
LICENSING,
OPERATIONAL KNOWLEDGE, & AUSTRALIAN & NEW ZEALAND CUSTOMERS
SERVED FROM FACILITY

Source text for Eikon:  ID:nCNW8WMZna 
Further company coverage:  LABS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))